Recruiting Pulmonary Hypertension Studies in Stony Brook
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or Without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive hematopoetic stem ce...
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma
This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin...
A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
This study is researching an experimental drug called odronextamab (referred to as study drug), in combination with lenalidomide. The study is focused on participants who have one of two types of canc...
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population...
About Pulmonary Hypertension Clinical Trials in Stony Brook
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 4 pulmonary hypertension clinical trials recruiting participants in Stony Brook, NY. These studies are seeking a combined 1,549 participants. Research is being sponsored by Karyopharm Therapeutics Inc, Regeneron Pharmaceuticals, West-Ward Pharmaceutical. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Stony Brook — FAQ
Are there pulmonary hypertension clinical trials in Stony Brook?
Yes, there are 4 pulmonary hypertension clinical trials currently recruiting in Stony Brook, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stony Brook?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stony Brook research site will contact you about next steps.
Are clinical trials in Stony Brook free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stony Brook studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 4 active trials in Stony Brook are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov